Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Sales | 31 | 32 | 31 | 31 | 31 |
| Gross Profit | 31 | 32 | 31 | 31 | 31 |
| Operating Expenses | 9,017 | 7,771 | 8,060 | 5,332 | 4,688 |
| Operating Income | -8,986 | -7,739 | -8,029 | -5,301 | -4,657 |
| Other Income | 8,112 | 9,335 | -8,133 | -11,779 | 179 |
| Pre-tax Income | -874 | 1,596 | -16,162 | -17,080 | -4,478 |
| Net Income Continuous | -874 | 1,596 | -16,162 | -17,080 | -4,478 |
| Net Income | $-874 | $1,596 | $-16,162 | $-17,080 | $-4,478 |
| EPS Basic Total Ops | -0.03 | 0.62 | -0.69 | -1.46 | -0.38 |
| EPS Basic Continuous Ops | -0.03 | 0.62 | -0.69 | -1.46 | -0.38 |
| EPS Diluted Total Ops | -0.03 | 0.62 | -0.69 | -1.46 | -0.38 |
| EPS Diluted Continuous Ops | -0.03 | 0.62 | -0.69 | -1.46 | -0.38 |
| EBITDA(a) | $-8,821 | $-7,561 | $-8,008 | $-5,294 | $-4,631 |